Compile Data Set for Download or QSAR
Found 453 with Last Name = 'ishizaka' and Initial = 't'
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260242(US9522914, A-44)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260242(US9522914, A-44)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222831(CHEMBL401132 | N-(5-tert-butyl-3-(cyclopropylmethy...)copy SMILEScopy InChI
Affinity DataIC50: 0.410nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260267(US9522914, B-20)copy SMILEScopy InChI
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260267(US9522914, B-20)copy SMILEScopy InChI
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260241(US9522914, A-43)copy SMILEScopy InChI
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260241(US9522914, A-43)copy SMILEScopy InChI
Affinity DataIC50: 0.490nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222845(CHEMBL247830 | N-(5-tert-butyl-3-(cyclopropylmethy...)copy SMILEScopy InChI
Affinity DataIC50: 0.5nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260347(US9522914, D-36)copy SMILEScopy InChI
Affinity DataIC50: 0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260347(US9522914, D-36)copy SMILEScopy InChI
Affinity DataIC50: 0.610nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM21311(4-(2-{3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]...)copy SMILEScopy InChI
Affinity DataIC50: 0.770nMAssay Description:Binding affinity to CB2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q208665CPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 0.820nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260206(US9522914, A-08)copy SMILEScopy InChI
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260206(US9522914, A-08)copy SMILEScopy InChI
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 0.820nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260237(US9522914, A-39)copy SMILEScopy InChI
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260237(US9522914, A-39)copy SMILEScopy InChI
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50375384(CHEMBL263913)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q208665CPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222841((Z)-3-bromo-N-(5-tert-butyl-3-(cyclopropylmethyl)-...)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222834(CHEMBL398713 | N-(5-tert-butyl-3-(cyclopropylmethy...)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
Taisho Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50375382(CHEMBL410014)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:Displacement of [3H]CP-55940 from CB1 receptor in Sprague-Dawley rat spleen membraneMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q208665CPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260248(US9522914, B-01)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260248(US9522914, B-01)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260264(US9522914, B-17)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260264(US9522914, B-17)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260329(US9522914, D-18)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260329(US9522914, D-18)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50375385(CHEMBL264154)copy SMILEScopy InChI
Affinity DataIC50: 1.70nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q208665CPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222832(CHEMBL248386 | N-(5-tert-butyl-3-(cyclopropylmethy...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetCannabinoid receptor 1(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Taisho Pharmaceutical Co., Ltd

Curated by ChEMBL
LigandPNGBDBM50072775(2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB1 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222833(CHEMBL555610 | N-(5-tert-butyl-3-(cyclopropylmethy...)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260308(US9522914, C-19)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260256(US9522914, B-09)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260256(US9522914, B-09)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260249(US9522914, B-02)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260308(US9522914, C-19)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260249(US9522914, B-02)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50222844(CHEMBL248015 | N-(5-tert-butyl-3-(2-ethoxyethyl)-4...)copy SMILEScopy InChI
Affinity DataIC50: 2.30nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PG1SJQPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260213(US9522914, A-15)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260213(US9522914, A-15)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260316(US9522914, D-05)copy SMILEScopy InChI
Affinity DataIC50: 2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260316(US9522914, D-05)copy SMILEScopy InChI
Affinity DataIC50: 2.5nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260220(US9522914, A-22)copy SMILEScopy InChI
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260220(US9522914, A-22)copy SMILEScopy InChI
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Taisho Pharmaceutical Co. Ltd

Curated by ChEMBL
LigandPNGBDBM50375383(CHEMBL440407)copy SMILEScopy InChI
Affinity DataIC50: 2.60nMAssay Description:Displacement of [3H]CP-55940 from human recombinant CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q208665CPubMed
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260352(US9522914, D-41)copy SMILEScopy InChI
Affinity DataIC50: 2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260352(US9522914, D-41)copy SMILEScopy InChI
Affinity DataIC50: 2.70nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2WM1CB9US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260255(US9522914, B-08)copy SMILEScopy InChI
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
TargetVasopressin V1b receptor(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD

US Patent
LigandPNGBDBM260341(US9522914, D-30)copy SMILEScopy InChI
Affinity DataIC50: 2.80nMpH: 7.4 T: 2°CAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2KS6PR7US Patent
Displayed 1 to 50 (of 453 total ) | Next | Last >>
Jump to: